Phreesia Stock Price, News & Analysis

Phreesia, a leader in patient intake solutions, has received certification from the Alliance for Audited Media (AAM) for its PatientConnect platform. This certification validates that the platform’s advertising measurement systems adhere to high industry standards. Phreesia’s commitment to continuous auditing ensures accuracy and reliability, maintaining industry-level performance. AAM’s ongoing audits include evaluating targeting criteria and patient authorization processes. The collaboration emphasizes Phreesia’s transparency and data integrity in the healthcare advertising sector.

Phreesia has joined the Zoom App Marketplace, enhancing its Intake for Telehealth solution. This integration offers automated patient intake processes for telehealth visits, allowing healthcare providers to generate unique meeting links and collect essential patient information efficiently. Over 100 healthcare organizations, including a 17-provider gastroenterology group, are already benefiting from this partnership. The streamlined registration improves the overall patient experience during virtual consultations.

Office Practicum (OP) has partnered with Phreesia to integrate their pediatric-specific EHR and patient intake management systems. This collaboration aims to enhance operational efficiency for pediatric practices by enabling seamless data capture during patient intake, improving the overall healthcare experience for families. OP's SVP of Product emphasized the accessibility of high-quality tools for practices, while Phreesia's CEO highlighted their shared mission of supporting pediatric care. The integration promises to streamline workflows, allowing for a convenient patient check-in process.

Phreesia, Inc. (NYSE: PHR) announced the retirement of CFO Tom Altier, effective April 2021, with Randy Rasmussen set to take over as CFO from May 1, 2021. Altier, who has been with Phreesia since 2012, will remain in an advisory role post-retirement. CEO Chaim Indig praised Altier's leadership in the company's successful transition to public status. Rasmussen, who joined as Chief Accounting Officer in 2019, brings over 25 years of finance experience to his new position. Phreesia provides healthcare organizations with innovative patient intake management solutions.

Phreesia, Inc. (NYSE: PHR) reported Q3 fiscal 2021 results with revenue of $38.5 million, a 17% increase year-over-year. The average number of provider clients rose to 1,737, marking a 10% growth. Average revenue per provider client reached $17,490, a 5% increase. Adjusted EBITDA was $1.2 million, down from $3.0 million in the prior year. Cash at the end of the quarter stood at $254.1 million, boosted by a follow-on stock offering. However, the company anticipates continued uncertainty due to COVID-19's impact on client operations and revenue.

Phreesia, Inc. (NYSE: PHR) will announce its fiscal Q3 2021 financial results on December 8, 2020, after market close. A conference call and webcast to discuss these results is scheduled for December 9, 2020, at 8:30 a.m. ET. The company provides healthcare organizations with innovative SaaS solutions to optimize patient intake processes, enhancing both patient engagement and clinical efficiency. Investors can participate in the call by dialing (866) 211-4557 or (647) 689-6750 internationally.

Phreesia, Inc. (NYSE: PHR) has closed an underwritten public offering of 5,750,000 shares of its common stock, including an additional 750,000 shares purchased through underwriters' options. The shares were priced at $32.00 each, yielding net proceeds of approximately $174.4 million after expenses. The offering was managed by J.P. Morgan and William Blair, among others. A prospectus supplement has been filed with the SEC, outlining the terms. Phreesia's platform enhances patient intake for healthcare organizations, improving efficiency and clinical care.

Phreesia, Inc. (NYSE:PHR) has priced its public offering of 5,000,000 shares of common stock at $32.00 per share, with a potential net proceeds of approximately $151.6 million, or $174.4 million if underwriters exercise their option for 750,000 additional shares. The offering is expected to close on October 23, 2020, subject to customary conditions. J.P. Morgan and William Blair serve as joint book-running managers. The offering's details are available via a prospectus supplement filed with the SEC.